OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Genomic Landscape of poorly Differentiated and Anaplastic Thyroid Carcinoma
Bin Xu, Ronald Ghossein
Endocrine Pathology (2016) Vol. 27, Iss. 3, pp. 205-212
Closed Access | Times Cited: 158
Bin Xu, Ronald Ghossein
Endocrine Pathology (2016) Vol. 27, Iss. 3, pp. 205-212
Closed Access | Times Cited: 158
Showing 1-25 of 158 citing articles:
The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults
Kepal N. Patel, Linwah Yip, Carrie C. Lubitz, et al.
Annals of Surgery (2020) Vol. 271, Iss. 3, pp. e21-e93
Closed Access | Times Cited: 417
Kepal N. Patel, Linwah Yip, Carrie C. Lubitz, et al.
Annals of Surgery (2020) Vol. 271, Iss. 3, pp. e21-e93
Closed Access | Times Cited: 417
2019 European Thyroid Association Guidelines for the Treatment and Follow-Up of Advanced Radioiodine-Refractory Thyroid Cancer
Laura Fugazzola, Rossella Elisei, Dagmar Führer, et al.
European Thyroid Journal (2019) Vol. 8, Iss. 5, pp. 227-245
Open Access | Times Cited: 240
Laura Fugazzola, Rossella Elisei, Dagmar Führer, et al.
European Thyroid Journal (2019) Vol. 8, Iss. 5, pp. 227-245
Open Access | Times Cited: 240
Dissecting Anaplastic Thyroid Carcinoma: A Comprehensive Clinical, Histologic, Immunophenotypic, and Molecular Study of 360 Cases
Bin Xu, Talia L. Fuchs, Snjezana Doğan, et al.
Thyroid (2020) Vol. 30, Iss. 10, pp. 1505-1517
Open Access | Times Cited: 210
Bin Xu, Talia L. Fuchs, Snjezana Doğan, et al.
Thyroid (2020) Vol. 30, Iss. 10, pp. 1505-1517
Open Access | Times Cited: 210
Novel targeted therapies and immunotherapy for advanced thyroid cancers
George E. Naoum, Michael Morkos, Brian W. Kim, et al.
Molecular Cancer (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 207
George E. Naoum, Michael Morkos, Brian W. Kim, et al.
Molecular Cancer (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 207
Comprehensive screening for PD-L1 expression in thyroid cancer
Soomin Ahn, Tae Hyuk Kim, Sun Wook Kim, et al.
Endocrine Related Cancer (2017) Vol. 24, Iss. 2, pp. 97-106
Open Access | Times Cited: 143
Soomin Ahn, Tae Hyuk Kim, Sun Wook Kim, et al.
Endocrine Related Cancer (2017) Vol. 24, Iss. 2, pp. 97-106
Open Access | Times Cited: 143
Real-World Experience with Targeted Therapy for the Treatment of Anaplastic Thyroid Carcinoma
Priyanka Iyer, Ramona Dadu, Renata Ferrarotto, et al.
Thyroid (2017) Vol. 28, Iss. 1, pp. 79-87
Open Access | Times Cited: 107
Priyanka Iyer, Ramona Dadu, Renata Ferrarotto, et al.
Thyroid (2017) Vol. 28, Iss. 1, pp. 79-87
Open Access | Times Cited: 107
Special types of thyroid carcinoma
Zubair Baloch, Virginia A. LiVolsi
Histopathology (2017) Vol. 72, Iss. 1, pp. 40-52
Closed Access | Times Cited: 103
Zubair Baloch, Virginia A. LiVolsi
Histopathology (2017) Vol. 72, Iss. 1, pp. 40-52
Closed Access | Times Cited: 103
Molecular Alterations in Thyroid Carcinoma
Mohamed Rizwan Haroon Al Rasheed, Bin Xu
Surgical pathology clinics (2019) Vol. 12, Iss. 4, pp. 921-930
Open Access | Times Cited: 101
Mohamed Rizwan Haroon Al Rasheed, Bin Xu
Surgical pathology clinics (2019) Vol. 12, Iss. 4, pp. 921-930
Open Access | Times Cited: 101
Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features Accounts for More Than Half of “Carcinomas” Harboring RAS Mutations
Vera Paulson, Priyanka Shivdasani, Trevor E. Angell, et al.
Thyroid (2017) Vol. 27, Iss. 4, pp. 506-511
Closed Access | Times Cited: 90
Vera Paulson, Priyanka Shivdasani, Trevor E. Angell, et al.
Thyroid (2017) Vol. 27, Iss. 4, pp. 506-511
Closed Access | Times Cited: 90
Molecular alterations of coexisting thyroid papillary carcinoma and anaplastic carcinoma: identification of TERT mutation as an independent risk factor for transformation
Naoki Oishi, Tetsuo Kondo, Aya Ebina, et al.
Modern Pathology (2017) Vol. 30, Iss. 11, pp. 1527-1537
Open Access | Times Cited: 89
Naoki Oishi, Tetsuo Kondo, Aya Ebina, et al.
Modern Pathology (2017) Vol. 30, Iss. 11, pp. 1527-1537
Open Access | Times Cited: 89
CAR T Therapy Targeting ICAM-1 Eliminates Advanced Human Thyroid Tumors
Irene M. Min, Enda Shevlin, Yogindra Vedvyas, et al.
Clinical Cancer Research (2017) Vol. 23, Iss. 24, pp. 7569-7583
Open Access | Times Cited: 88
Irene M. Min, Enda Shevlin, Yogindra Vedvyas, et al.
Clinical Cancer Research (2017) Vol. 23, Iss. 24, pp. 7569-7583
Open Access | Times Cited: 88
Anaplastic thyroid carcinoma: an epidemiologic, histologic, immunohistochemical, and molecular single-institution study
Audrey Deeken-Draisey, Guang‐Yu Yang, Juehua Gao, et al.
Human Pathology (2018) Vol. 82, pp. 140-148
Closed Access | Times Cited: 88
Audrey Deeken-Draisey, Guang‐Yu Yang, Juehua Gao, et al.
Human Pathology (2018) Vol. 82, pp. 140-148
Closed Access | Times Cited: 88
Primary high‐grade non‐anaplastic thyroid carcinoma: a retrospective study of 364 cases
Bin Xu, J. Godwin David, Snjezana Doğan, et al.
Histopathology (2021) Vol. 80, Iss. 2, pp. 322-337
Open Access | Times Cited: 69
Bin Xu, J. Godwin David, Snjezana Doğan, et al.
Histopathology (2021) Vol. 80, Iss. 2, pp. 322-337
Open Access | Times Cited: 69
Molecular Profile of Advanced Thyroid Carcinomas by Next-Generation Sequencing: Characterizing Tumors Beyond Diagnosis for Targeted Therapy
Hui Chen, Rajyalakshmi Luthra, Mark J. Routbort, et al.
Molecular Cancer Therapeutics (2018) Vol. 17, Iss. 7, pp. 1575-1584
Open Access | Times Cited: 75
Hui Chen, Rajyalakshmi Luthra, Mark J. Routbort, et al.
Molecular Cancer Therapeutics (2018) Vol. 17, Iss. 7, pp. 1575-1584
Open Access | Times Cited: 75
Spectrum of TERT promoter mutations and mechanisms of activation in thyroid cancer
Federica Panebianco, Alyaksandr V. Nikitski, Marina N. Nikiforova, et al.
Cancer Medicine (2019) Vol. 8, Iss. 13, pp. 5831-5839
Open Access | Times Cited: 71
Federica Panebianco, Alyaksandr V. Nikitski, Marina N. Nikiforova, et al.
Cancer Medicine (2019) Vol. 8, Iss. 13, pp. 5831-5839
Open Access | Times Cited: 71
Clinical outcomes in high-risk squamous cell carcinoma patients treated with Mohs micrographic surgery alone
Gerardo Marrazzo, John A. Zitelli, David G. Brodland
Journal of the American Academy of Dermatology (2018) Vol. 80, Iss. 3, pp. 633-638
Closed Access | Times Cited: 69
Gerardo Marrazzo, John A. Zitelli, David G. Brodland
Journal of the American Academy of Dermatology (2018) Vol. 80, Iss. 3, pp. 633-638
Closed Access | Times Cited: 69
Utilities of RAS Mutations in Preoperative Fine Needle Biopsies for Decision Making for Thyroid Nodule Management: Results from a Single-Center Prospective Cohort
Haixia Guan, Gianluca Toraldo, Sandra Cerda, et al.
Thyroid (2020) Vol. 30, Iss. 4, pp. 536-547
Closed Access | Times Cited: 52
Haixia Guan, Gianluca Toraldo, Sandra Cerda, et al.
Thyroid (2020) Vol. 30, Iss. 4, pp. 536-547
Closed Access | Times Cited: 52
Molecular Genetics of Follicular-Derived Thyroid Cancer
Elisabetta Macerola, Anello Marcello Poma, Paola Vignali, et al.
Cancers (2021) Vol. 13, Iss. 5, pp. 1139-1139
Open Access | Times Cited: 45
Elisabetta Macerola, Anello Marcello Poma, Paola Vignali, et al.
Cancers (2021) Vol. 13, Iss. 5, pp. 1139-1139
Open Access | Times Cited: 45
The differences in distant metastatic patterns and their corresponding survival between thyroid cancer subtypes
Huy Gia Vuong, Minh‐Khang Le, Lewis Hassell, et al.
Head & Neck (2022) Vol. 44, Iss. 4, pp. 926-932
Open Access | Times Cited: 36
Huy Gia Vuong, Minh‐Khang Le, Lewis Hassell, et al.
Head & Neck (2022) Vol. 44, Iss. 4, pp. 926-932
Open Access | Times Cited: 36
TTN mutations predict a poor prognosis in patients with thyroid cancer
Xiudan Han, Jianrong Chen, Jiao Wang, et al.
Bioscience Reports (2022) Vol. 42, Iss. 7
Open Access | Times Cited: 33
Xiudan Han, Jianrong Chen, Jiao Wang, et al.
Bioscience Reports (2022) Vol. 42, Iss. 7
Open Access | Times Cited: 33
Molecular Profiling for Bethesda III to VI Nodules: Results of a Multicenter International Retrospective Study
Grégoire B. Morand, Idit Tessler, Maxine Noik, et al.
Endocrine Practice (2024) Vol. 30, Iss. 4, pp. 319-326
Closed Access | Times Cited: 7
Grégoire B. Morand, Idit Tessler, Maxine Noik, et al.
Endocrine Practice (2024) Vol. 30, Iss. 4, pp. 319-326
Closed Access | Times Cited: 7
Clinical utility of EZH1 mutations in the diagnosis of follicular-patterned thyroid tumors
Chan Kwon Jung, Yourha Kim, Sora Jeon, et al.
Human Pathology (2018) Vol. 81, pp. 9-17
Open Access | Times Cited: 59
Chan Kwon Jung, Yourha Kim, Sora Jeon, et al.
Human Pathology (2018) Vol. 81, pp. 9-17
Open Access | Times Cited: 59
PD-L1 and IDO1 Are Expressed in Poorly Differentiated Thyroid Carcinoma
Matthew W. Rosenbaum, Benjamin J. Gigliotti, Sara I. Pai, et al.
Endocrine Pathology (2018) Vol. 29, Iss. 1, pp. 59-67
Open Access | Times Cited: 57
Matthew W. Rosenbaum, Benjamin J. Gigliotti, Sara I. Pai, et al.
Endocrine Pathology (2018) Vol. 29, Iss. 1, pp. 59-67
Open Access | Times Cited: 57
Molecular pathology and thyroid FNA
David Poller, Sharon Glaysher
Cytopathology (2017) Vol. 28, Iss. 6, pp. 475-481
Open Access | Times Cited: 55
David Poller, Sharon Glaysher
Cytopathology (2017) Vol. 28, Iss. 6, pp. 475-481
Open Access | Times Cited: 55
Primary Thyroid Carcinoma with Low-Risk Histology and Distant Metastases: Clinicopathologic and Molecular Characteristics
Bin Xu, R. Michael Tuttle, Mona M. Sabra, et al.
Thyroid (2017) Vol. 27, Iss. 5, pp. 632-640
Open Access | Times Cited: 54
Bin Xu, R. Michael Tuttle, Mona M. Sabra, et al.
Thyroid (2017) Vol. 27, Iss. 5, pp. 632-640
Open Access | Times Cited: 54
